| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.12 | 0.008 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.008 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.089 | 0.008 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |